Literature DB >> 18957812

Possible involvement of Rho-kinase in aldosterone-induced vascular smooth muscle cell remodeling.

Kayoko Miyata1, Hirofumi Hitomi, Peng Guo, Guo-Xing Zhang, Shoji Kimura, Hideyasu Kiyomoto, Naohisa Hosomi, Shoji Kagami, Masakazu Kohno, Akira Nishiyama.   

Abstract

There is increasing evidence supporting potential roles of aldosterone in the pathogenesis of vascular injury. The present study aimed to determine the involvement of Rho-kinase in aldosterone-induced vascular smooth muscle cell (VSMC) remodeling. In cultured rat VSMC, the effects of aldosterone on Rho-kinase activity, the reorganization of the cytoskeleton and cellular migration were examined. Aldosterone (1 nmol/L) significantly increased phosphorylation of myosin phosphate target subunit-1 (MYPT1), a marker of Rho-kinase activity, and the amount of GTP-Rho with a peak at 90 min in VSMC. Aldosterone also stimulated VSMC stress fiber formation and migration. These effects of aldosterone were markedly attenuated by pretreatment with eplerenone (10 micromol/L), a selective mineralocorticoid receptor antagonist, or Y27632 (10 micromol/L), a specific Rho-kinase inhibitor. These findings indicate that Rho-kinase is involved in the pathogenesis of aldosterone-induced VSMC remodeling.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18957812     DOI: 10.1291/hypres.31.1407

Source DB:  PubMed          Journal:  Hypertens Res        ISSN: 0916-9636            Impact factor:   3.872


  10 in total

Review 1.  Direct role for smooth muscle cell mineralocorticoid receptors in vascular remodeling: novel mechanisms and clinical implications.

Authors:  Jenny B Koenig; Iris Z Jaffe
Journal:  Curr Hypertens Rep       Date:  2014-05       Impact factor: 5.369

2.  Effect of aldosterone-producing adenoma on endothelial function and Rho-associated kinase activity in patients with primary aldosteronism.

Authors:  Takeshi Matsumoto; Kenji Oki; Masato Kajikawa; Ayumu Nakashima; Tatsuya Maruhashi; Yumiko Iwamoto; Akimichi Iwamoto; Nozomu Oda; Takayuki Hidaka; Yasuki Kihara; Nobuoki Kohno; Kazuaki Chayama; Chikara Goto; Yoshiki Aibara; Kensuke Noma; James K Liao; Yukihito Higashi
Journal:  Hypertension       Date:  2015-01-26       Impact factor: 10.190

3.  Eplerenone improves endothelial function and arterial stiffness and inhibits Rho-associated kinase activity in patients with idiopathic hyperaldosteronism: a pilot study.

Authors:  Shinji Kishimoto; Kenji Oki; Tatsuya Maruhashi; Masato Kajikawa; Shogo Matsui; Haruki Hashimoto; Yuji Takaeko; Yasuki Kihara; Kazuaki Chayama; Chikara Goto; Yoshiki Aibara; Farina Mohamad Yusoff; Ayumu Nakashima; Kensuke Noma; James K Liao; Yukihito Higashi
Journal:  J Hypertens       Date:  2019-05       Impact factor: 4.844

4.  Effects of spironolactone on cerebral vessel structure in rats with sustained hypertension.

Authors:  Christiné S Rigsby; Adviye Ergul; Vera Portik Dobos; David M Pollock; Anne M Dorrance
Journal:  Am J Hypertens       Date:  2011-02-24       Impact factor: 2.689

5.  Aldosterone enhances IGF-I-mediated signaling and biological function in vascular smooth muscle cells.

Authors:  Teresa Cascella; Yashwanth Radhakrishnan; Laura A Maile; Walker H Busby; Katherine Gollahon; Annamaria Colao; David R Clemmons
Journal:  Endocrinology       Date:  2010-09-29       Impact factor: 4.736

Review 6.  Primary Aldosteronism and Resistant Hypertension: A Pathophysiological Insight.

Authors:  Fabio Bioletto; Martina Bollati; Chiara Lopez; Stefano Arata; Matteo Procopio; Federico Ponzetto; Ezio Ghigo; Mauro Maccario; Mirko Parasiliti-Caprino
Journal:  Int J Mol Sci       Date:  2022-04-27       Impact factor: 6.208

7.  Resveratrol inhibits migration and Rac1 activation in EGF- but not PDGF-activated vascular smooth muscle cells.

Authors:  Mario Kumerz; Elke H Heiss; Daniel Schachner; Atanas G Atanasov; Verena M Dirsch
Journal:  Mol Nutr Food Res       Date:  2011-07-05       Impact factor: 5.914

8.  Inhibition of extracellular signal-regulated kinases ameliorates hypertension-induced renal vascular remodeling in rat models.

Authors:  Li Jing; Jianzhong Zhang; Jinping Sun; Fengying Guo; Xin An; Kan Yang; Ping Andy Li
Journal:  Int J Mol Sci       Date:  2011-11-28       Impact factor: 5.923

Review 9.  The involvement of aldosterone on vascular insulin resistance: implications in obesity and type 2 diabetes.

Authors:  Thiago Bruder-Nascimento; Marcondes Ab da Silva; Rita C Tostes
Journal:  Diabetol Metab Syndr       Date:  2014-08-24       Impact factor: 3.320

10.  Danhong injection reduces vascular remodeling and up-regulates the Kallikrein-kinin system in spontaneously hypertensive rats.

Authors:  Xiaohu Yang; John Orgah; Dandan Wang; Guanwei Fan; Hu Jingyang; Jihong Han; Gangjian Qin; Xiumei Gao; Yan Zhu
Journal:  Sci Rep       Date:  2017-06-27       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.